Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVoCaDO: IV Vitamin C in COVID-19 and Hypoxia
NCT04357782Phase 2Completed
- Sponsor
- Richmond VA Medical Center
- Start
- Apr 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in coronavirus disease 2019 (COVID-19), hypoxia, sponsored by Richmond VA Medical Center. Started Apr 2020; status: completed.
02
Drugs
ascorbic acid
03
Conditions
coronavirus disease 2019 (COVID-19)hypoxia
Beyond the preview
Go deeper on NCT04357782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04357782.